Sansure Biotech Inc Cash Flow Reinvestment Rate
Sansure Biotech Inc cash flow reinvestment rate. Sansure Biotech Inc (688289) has a Cash Flow Reinvestment Rate of 1.06x as of September 2025, reinvesting CN¥63.08 Million (capex CN¥63.08 Million ) from operating cash flow of CN¥59.72 Million. See Sansure Biotech Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Sansure Biotech Inc (2018–2025)
Cash flow reinvestment rate of Sansure Biotech Inc from 2018 to 2025. Historical reinvestment intensity for Sansure Biotech Inc across 8 annual periods. Explore how well can Sansure Biotech Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Sansure Biotech Inc Cash Flow Reinvestment Rate by Year (2018–2025)
Sansure Biotech Inc cash flow reinvestment rate by year from 2018 to 2025. Year-by-year capital reinvestment analysis for Sansure Biotech Inc. For the full cash flow conversion analysis, see how efficiently does Sansure Biotech Inc generate cash.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.12x | CN¥573.17 Million | CN¥183.96 Million | CN¥369.77 Million | ▲ +7.0% |
| 2024 | 2.91x | CN¥799.38 Million | CN¥274.45 Million | CN¥421.10 Million | ▼ -81.6% |
| 2023 | 15.86x | CN¥1.79 Billion | CN¥112.82 Million | CN¥391.35 Million | ▲ +2251.7% |
| 2022 | 0.67x | CN¥1.73 Billion | CN¥2.56 Billion | CN¥558.83 Million | ▼ -14.8% |
| 2021 | 0.79x | CN¥1.49 Billion | CN¥1.88 Billion | CN¥372.86 Million | ▲ +14.6% |
| 2020 | 0.69x | CN¥1.82 Billion | CN¥2.64 Billion | CN¥108.67 Million | ▼ -88.0% |
| 2019 | 5.75x | CN¥128.74 Million | CN¥22.41 Million | CN¥34.14 Million | ▲ +75.8% |
| 2018 | 3.27x | CN¥32.90 Million | CN¥10.07 Million | CN¥32.90 Million | — |